SOTK

Sono-Tek Corp (SOTK) Q3 2026 Filing Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended November 30, 2025 (Third Quarter of Fiscal Year 2026) and the nine months ended on that date. Sono-Tek Corporation is a global leader in designing and manufacturing ultrasonic coating systems for microelectronics, alternative energy, medical, and industrial markets. The company operates as a single segment and is classified as a non-accelerated filer and smaller reporting company.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Mix Shift: While total revenue was flat year-over-year (-1% for 9 months), the product mix shifted significantly. In-Line Coating Systems revenue surged 126% (9 months) driven by high-ASP solar system shipments, offsetting a 46% decline in Multi-Axis Coating Systems due to reduced electrolysis demand.
• Margin Expansion: Gross margin improved by 330 basis points (9 months) to 51%, attributed to a favorable mix of mature high-ASP systems, reduced manufacturing costs, and strong U.S. sales which carry less distributor discounting.
• Profitability Growth: Operating income increased 69% for the nine-month period, and Net Income rose 32%, driven by gross profit expansion and operating leverage.
• Backlog: Combined equipment and service backlog reached a record $12.26 million, up 16% year-over-year.
• Cash Flow: Net cash provided by operating activities decreased to $0.11 million (9 months) from $1.20 million in the prior year, primarily due to a $2.06 million increase in accounts receivable and a decrease in customer deposits.

Outlook, Risks, and Management Commentary

• Market Trends: Medical sales grew 37% (9 months) driven by balloon catheter and stent coating systems. Alternative energy sales were flat for the nine months but declined in the quarter due to shifting U.S. government policy incentives for electrolysis.
• Tax Legislation: The "One Big Beautiful Bill Act" (OBBBA), signed July 4, 2025, restored 100% bonus depreciation and reinstated immediate expensing of R&D costs. This impacted current and deferred tax calculations, potentially generating tax refunds for retroactive R&D expensing.
• Liquidity: The company maintains a strong balance sheet with no debt and $11.72 million in liquid assets. A $1.5 million revolving line of credit is available, with $1.39 million unused.
• Risks: Key risks include customer concentration (one customer accounted for 38% of 9-month sales and 67% of receivables), foreign exchange exposure (37% of sales are international), and dependence on government incentives for the alternative energy sector.
• Guidance: Management expects wide variations in order flow and shipments quarter-to-quarter. No specific numerical guidance was provided in this text.

Investor Verification Checklist

• Customer Concentration: Verify the financial stability of the single customer representing 38% of 9-month sales and 67% of accounts receivable.
• Receivables Quality: Assess the $2.06 million increase in accounts receivable, specifically the modified payment terms granted to a major solar customer.
• Policy Sensitivity: Monitor the impact of U.S. government policy changes on the Alternative Energy sector, which caused a 35% sales decline in Q3.
• Backlog Conversion: Track the conversion rate of the record $12.26 million backlog into recognized revenue in upcoming quarters.
• Tax Refunds: Confirm the realization of potential tax refunds from the retroactive R&D expensing provisions of the OBBBA.